MARZO, TIZIANO Statistiche
MARZO, TIZIANO
DIPARTIMENTO DI FARMACIA
Description of a Non-Canonical AsPt Blue Species Originating from the Aerobic Oxidation of AP-1 in Aqueous Solution
2024-01-01 Cirri, Damiano; Marzo, Tiziano; Mastrorilli, Piero; Petrelli, Valentina; Todisco, Stefano; De Giglio, Elvira; Gellini, Cristina; Ricci, Marilena; Pratesi, Alessandro; Messori, Luigi
Dimolybdenum (II,II) paddlewheel complexes bearing non-steroidal anti-inflammatory drug ligands: Insights into the chemico-physical profile and first biological assessment
2024-01-01 Chiaverini, Lorenzo; Notarstefano, Valentina; Tolbatov, Iogann; Umari, Paolo; Giorgini, Elisabetta; Ciccone, Lidia; Di Leo, Riccardo; Trincavelli, Letizia; Giacomelli, Chiara; Marchetti, Laura; Marzo, Tiziano; La Mendola, Diego; Marrone, Alessandro
Oxaliplatin(IV) Prodrugs Functionalized with Gemcitabine and Capecitabine Induce Blockage of Colorectal Cancer Cell Growth - An Investigation of the Activation Mechanism and Their Nanoformulation
2024-01-01 Marotta, Carlo; Cirri, Damiano; Kanavos, Ioannis; Ronga, Luisa; Lobinski, Ryszard; Funaioli, Tiziana; Giacomelli, Chiara; Barresi, Elisabetta; Trincavelli, Maria Letizia; Marzo, Tiziano; Pratesi, Alessandro
The binding of auranofin at DNA/RNA nucleobases: A DFT assessment
2024-01-01 Tolbatov, Iogann; Umari, Paolo; Marzo, Tiziano; Chiaverini, Lorenzo; LA MENDOLA, Diego; Marrone, Alessandro
Unveiling the mechanism of activation of the Te(IV) prodrug AS101. New chemical insights towards a better understanding of its medicinal properties
2024-01-01 Chiaverini, Lorenzo; Tolbatov, Iogann; Marrone, Alessandro; Marzo, Tiziano; Biver, Tarita; La Mendola, Diego
A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt3)]+ pharmacophore is highly cytotoxic against ovarian cancer cells
2023-01-01 Chiaverini, Lorenzo; Baglini, Emma; Mannelli, Michele; Poggetti, Valeria; Da Settimo, Federico; Taliani, Sabrina; Gamberi, Tania; Barresi, Elisabetta; La Mendola, Diego; Marzo, Tiziano
An unprecedented palladium-arsenic catalytic cycle for nitriles hydration
2023-01-01 Cirri, D.; Marzo, T.; Pratesi, A.
Cisplatin binding to angiogenin protein: new molecular pathways and targets for the drug's anticancer activity
2023-01-01 Ferraro, Giarita; Sanfilippo, Vanessa; Chiaverini, Lorenzo; Satriano, Cristina; Marzo, Tiziano; Merlino, Antonello; La Mendola, Diego
Diruthenium(ii,iii) paddlewheel complexes: effects of bridging and axial ligands on anticancer properties
2023-01-01 Tolbatov, I; Barresi, E; Taliani, S; La Mendola, D; Marzo, T; Marrone, A
Exploiting the Chemical Diversity of Metal Compounds as a Source of Novel Anti-COVID-19 Drugs
2023-01-01 Cirri, Damiano; Marotta, Carlo; Pratesi, Alessandro; Marzo, Tiziano; Messori, Luigi
Inorganic Drugs as a Tool for Protein Structure Solving and Studies on Conformational Changes
2023-01-01 Tolbatov, Iogann; Marrone, Alessandro; Shepard, William; Chiaverini, Lorenzo; Upadhyay Kahaly, Mousumi; La Mendola, Diego; Marzo, Tiziano; Ciccone, Lidia
Mechanistic Evaluations of the Effects of Auranofin Triethylphosphine Replacement with a Trimethylphosphite Moiety
2023-01-01 Ronga, Luisa; Tolbatov, Iogann; Giorgi, Ester; Pisarek, Paulina; Enjalbal, Christine; Marrone, Alessandro; Tesauro, Diego; Lobinski, Ryszard; Marzo, Tiziano; Cirri, Damiano; Pratesi, Alessandro
Pd-Based Hybrid Nanoparticles As Multimodal Theranostic Nanomedicine
2023-01-01 Bellissima, A.; Cucci, L. M.; Sanfilippo, V.; De Bonis, A.; Fiorenza, R.; Scire, S.; Marzo, T.; Severi, M.; La Mendola, D.; Notarstefano, V.; Giorgini, E.; Satriano, C.
Tyrosine kinase inhibitors (TKIs) for ovarian cancer treatment: from organic to inorganic chemotherapeutics towards selectivity-a perspective overview
2023-01-01 Baglini, Emma; Chiaverini, Lorenzo; Tolbatov, Iogann; Taliani, Sabrina; Da Settimo, Federico; La Mendola, Diego; Barresi, Elisabetta; Marzo, Tiziano
A Graphene Oxide-Angiogenin Theranostic Nanoplatform for the Therapeutic Targeting of Angiogenic Processes: The Effect of Copper-Supplemented Medium
2022-01-01 Riela, L; Cucci, Lm; Hansson, O; Marzo, T; La Mendola, D; Satriano, C
Anti-Staphylococcal Activity of the Auranofin Analogue Bearing Acetylcysteine in Place of the Thiosugar: An Experimental and Theoretical Investigation
2022-01-01 Chiaverini, L.; Pratesi, A.; Cirri, D.; Nardinocchi, A.; Tolbatov, I.; Marrone, A.; Di Luca, M.; Marzo, T.; La Mendola, D.
AS101: An overview on a leading tellurium-based prodrug
2022-01-01 Chiaverini, L.; Marzo, T.; La Mendola, D.
Auranofin and its analogs as prospective agents for the treatment of colorectal cancer
2022-01-01 Massai, L.; Cirri, D.; Marzo, T.; Messori, L.
Cancer Immunotherapy: An Overview on Small Molecules as Inhibitors of the Immune Checkpoint PD-1/PD-L1 (2015-2021)
2022-01-01 Baglini, Emma; Salerno, Silvia; Barresi, Elisabetta; Marzo, Tiziano; Settimo, Federico Da; Taliani, Sabrina
Is the Next Cisplatin Already in Our Laboratory?
2022-01-01 Cirri, D.; Chiaverini, L.; Pratesi, A.; Marzo, T.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Description of a Non-Canonical AsPt Blue Species Originating from the Aerobic Oxidation of AP-1 in Aqueous Solution | 1-gen-2024 | Cirri, Damiano; Marzo, Tiziano; Mastrorilli, Piero; Petrelli, Valentina; Todisco, Stefano; De Giglio, Elvira; Gellini, Cristina; Ricci, Marilena; Pratesi, Alessandro; Messori, Luigi | |
| Dimolybdenum (II,II) paddlewheel complexes bearing non-steroidal anti-inflammatory drug ligands: Insights into the chemico-physical profile and first biological assessment | 1-gen-2024 | Chiaverini, Lorenzo; Notarstefano, Valentina; Tolbatov, Iogann; Umari, Paolo; Giorgini, Elisabetta; Ciccone, Lidia; Di Leo, Riccardo; Trincavelli, Letizia; Giacomelli, Chiara; Marchetti, Laura; Marzo, Tiziano; La Mendola, Diego; Marrone, Alessandro | |
| Oxaliplatin(IV) Prodrugs Functionalized with Gemcitabine and Capecitabine Induce Blockage of Colorectal Cancer Cell Growth - An Investigation of the Activation Mechanism and Their Nanoformulation | 1-gen-2024 | Marotta, Carlo; Cirri, Damiano; Kanavos, Ioannis; Ronga, Luisa; Lobinski, Ryszard; Funaioli, Tiziana; Giacomelli, Chiara; Barresi, Elisabetta; Trincavelli, Maria Letizia; Marzo, Tiziano; Pratesi, Alessandro | |
| The binding of auranofin at DNA/RNA nucleobases: A DFT assessment | 1-gen-2024 | Tolbatov, Iogann; Umari, Paolo; Marzo, Tiziano; Chiaverini, Lorenzo; LA MENDOLA, Diego; Marrone, Alessandro | |
| Unveiling the mechanism of activation of the Te(IV) prodrug AS101. New chemical insights towards a better understanding of its medicinal properties | 1-gen-2024 | Chiaverini, Lorenzo; Tolbatov, Iogann; Marrone, Alessandro; Marzo, Tiziano; Biver, Tarita; La Mendola, Diego | |
| A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt3)]+ pharmacophore is highly cytotoxic against ovarian cancer cells | 1-gen-2023 | Chiaverini, Lorenzo; Baglini, Emma; Mannelli, Michele; Poggetti, Valeria; Da Settimo, Federico; Taliani, Sabrina; Gamberi, Tania; Barresi, Elisabetta; La Mendola, Diego; Marzo, Tiziano | |
| An unprecedented palladium-arsenic catalytic cycle for nitriles hydration | 1-gen-2023 | Cirri, D.; Marzo, T.; Pratesi, A. | |
| Cisplatin binding to angiogenin protein: new molecular pathways and targets for the drug's anticancer activity | 1-gen-2023 | Ferraro, Giarita; Sanfilippo, Vanessa; Chiaverini, Lorenzo; Satriano, Cristina; Marzo, Tiziano; Merlino, Antonello; La Mendola, Diego | |
| Diruthenium(ii,iii) paddlewheel complexes: effects of bridging and axial ligands on anticancer properties | 1-gen-2023 | Tolbatov, I; Barresi, E; Taliani, S; La Mendola, D; Marzo, T; Marrone, A | |
| Exploiting the Chemical Diversity of Metal Compounds as a Source of Novel Anti-COVID-19 Drugs | 1-gen-2023 | Cirri, Damiano; Marotta, Carlo; Pratesi, Alessandro; Marzo, Tiziano; Messori, Luigi | |
| Inorganic Drugs as a Tool for Protein Structure Solving and Studies on Conformational Changes | 1-gen-2023 | Tolbatov, Iogann; Marrone, Alessandro; Shepard, William; Chiaverini, Lorenzo; Upadhyay Kahaly, Mousumi; La Mendola, Diego; Marzo, Tiziano; Ciccone, Lidia | |
| Mechanistic Evaluations of the Effects of Auranofin Triethylphosphine Replacement with a Trimethylphosphite Moiety | 1-gen-2023 | Ronga, Luisa; Tolbatov, Iogann; Giorgi, Ester; Pisarek, Paulina; Enjalbal, Christine; Marrone, Alessandro; Tesauro, Diego; Lobinski, Ryszard; Marzo, Tiziano; Cirri, Damiano; Pratesi, Alessandro | |
| Pd-Based Hybrid Nanoparticles As Multimodal Theranostic Nanomedicine | 1-gen-2023 | Bellissima, A.; Cucci, L. M.; Sanfilippo, V.; De Bonis, A.; Fiorenza, R.; Scire, S.; Marzo, T.; Severi, M.; La Mendola, D.; Notarstefano, V.; Giorgini, E.; Satriano, C. | |
| Tyrosine kinase inhibitors (TKIs) for ovarian cancer treatment: from organic to inorganic chemotherapeutics towards selectivity-a perspective overview | 1-gen-2023 | Baglini, Emma; Chiaverini, Lorenzo; Tolbatov, Iogann; Taliani, Sabrina; Da Settimo, Federico; La Mendola, Diego; Barresi, Elisabetta; Marzo, Tiziano | |
| A Graphene Oxide-Angiogenin Theranostic Nanoplatform for the Therapeutic Targeting of Angiogenic Processes: The Effect of Copper-Supplemented Medium | 1-gen-2022 | Riela, L; Cucci, Lm; Hansson, O; Marzo, T; La Mendola, D; Satriano, C | |
| Anti-Staphylococcal Activity of the Auranofin Analogue Bearing Acetylcysteine in Place of the Thiosugar: An Experimental and Theoretical Investigation | 1-gen-2022 | Chiaverini, L.; Pratesi, A.; Cirri, D.; Nardinocchi, A.; Tolbatov, I.; Marrone, A.; Di Luca, M.; Marzo, T.; La Mendola, D. | |
| AS101: An overview on a leading tellurium-based prodrug | 1-gen-2022 | Chiaverini, L.; Marzo, T.; La Mendola, D. | |
| Auranofin and its analogs as prospective agents for the treatment of colorectal cancer | 1-gen-2022 | Massai, L.; Cirri, D.; Marzo, T.; Messori, L. | |
| Cancer Immunotherapy: An Overview on Small Molecules as Inhibitors of the Immune Checkpoint PD-1/PD-L1 (2015-2021) | 1-gen-2022 | Baglini, Emma; Salerno, Silvia; Barresi, Elisabetta; Marzo, Tiziano; Settimo, Federico Da; Taliani, Sabrina | |
| Is the Next Cisplatin Already in Our Laboratory? | 1-gen-2022 | Cirri, D.; Chiaverini, L.; Pratesi, A.; Marzo, T. |